Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2022 Sep 16;22(5):646-650.
doi: 10.17305/bjbms.2021.6977.

The Oncology Association of Bosnia and Herzegovina's recommendations for fertility preservation in oncologic patients

Timur Cerić  1 , Emir Sokolović  1 , Berisa Hasanbegović  1 , Anes Pašić  1 , Zdenka Gojković  2 , Jelena Vladičić Mašić  3 , Nikolina Dukić  3 , Inga Marijanović  4 , Alma Mekić Abazović  5 , Ibrahim Šišić  5 , Dijana Koprić  6 , Mustafa Hammami  7 , Senad Bajramović  8 , Taib Delić  9 , Semir Bešlija  1
Affiliations
Practice Guideline

The Oncology Association of Bosnia and Herzegovina's recommendations for fertility preservation in oncologic patients

Timur Cerić et al. Bosn J Basic Med Sci. .

Abstract

Malignancy is one of the major public health problems in Bosnia and Herzegovina. Along with breakthroughs in specific oncological therapy, improving the quality of life of cancer patients and management of therapy-induced side effects need to be recognized as a priority in the comprehensive cancer patient care. Fertility loss after cancer treatment is a field requiring special attention due to its various consequences on patients themselves. Although oncofertility is well-recognized area of oncology, low- to middle-income countries are facing issues with its implementation in everyday practice. Increased awareness about fertility preservation is of high priority for all specialists who participate in the medical care of cancer patients. The absence of a systemic solution and lack of expertise led to the founding of Fertility Preservation Working Group of the Oncology Association of Bosnia and Herzegovina. We have made recommendationsas an expert consensus with the ultimate goal of making the first step towards enhancement of oncofertility implementation in Bosnia and Herzegovina.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Semir Bešlija, Timur Cerić, Berisa Hasanbegović, Inga Marijanović, and Alma Mekić Abazović have participated in educational events that was supported by unrestricted grants from Zentiva. Other authors declare no conflicts of interest.

References

    1. World Health Organization International Agency for Research on Cancer (IARC) GLOBOCAN 2020:Estimated Cancer Incidence, Mortality and Prevalence Worldwide in. 2020 2020. [[Last accessed on 2021 mOct d27]]. Available from: https://www.gco.iarc.fr/today/data/factsheets/populations/70-bosnia-and-... .
    1. Patrizio P, Butts S, Caplan A. Ovarian tissue preservation and future fertility:emerging technologies and ethical considerations. J Natl Cancer Inst Monogr. 2005;34:107–10. https://doi.org/10.1093/jncimonographs/lgi023. - PubMed
    1. De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet. 2014;384(9950):1302–10. https://doi.org/10.1016/S0140-6736(14)60834-5. - PMC - PubMed
    1. Bourlon MT, Anazodo A, Woodruff TK, Segelov E. Oncofertility as a universal right and a global oncology priority. JCO Glob Oncol. 2020;6:314–6. https://doi.org/10.1200/GO.19.00337. - PMC - PubMed
    1. Rashedi AS, de Roo SF, Ataman LM, Edmonds ME, Silva AA, Scarella A, et al. Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe. JCO Glob Oncol. 2020;6:008144. https://doi.org/10.1200/JGO.2016.008144. - PMC - PubMed

Publication types